Abstract
By integrating genetic data into the traditional histology and immunohistochemistry-based classification system the revised WHO-classification of malignant tumours (2004) defined additional renal cell carcinoma subtypes, thereby enabling the application of additional diagnostic procedures. Therapy for advanced clear cell renal cell carcinoma has also seen significant progress. This report focuses on these developments, pinpoints current obstacles and provides future prospects.
Owner only: item control page
Altmetric
Altmetric